Showing results 1 to 20 of 23
next >
| Issue Date | Title | Author(s) |
| 2019 | Association between hand-foot skin reaction (HFSR) and survival benefit of fruquintinib in FRESCO trial. | Li, Jin; Qin, Shukui; Bai, Yuxian; Deng, Yanhong; Yang, Lei; Xu, Ruihua; Chen, Zhendong; Zhong, Haijun; Pan, Hongming; Guo, Weijian; Shu, Yongqian; Yuan, Ying; Xu, Jianming; Shen, Lin; Wang, Ning; Zhu, Chao; Fan, Songhua; Gong, Wei; Wang, Wei |
| 2019 | Camrelizumab combined with capecitabine and oxaliplatin followed by camrelizumab and apatinib as first-line therapy for advanced or metastatic gastric or gastroesophageal junction cancer: Updated results from a multicenter, open label phase II trial. | Shen, Lin; Peng, Zhi; Zhang, Yan-Qiao; Wei, Jia; Wang, Feng; Ying, Jieer; Deng, Yanhong; Gu, Kangsheng; Cheng, Ying; Yuan, Xianglin; Xiao, Juxiang; Wang, Linna; Zou, Jianjun |
| 1-Jun-2021 | Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction | Peng, Zhi; Wei, Jia; Wang, Feng; Ying, Jieer; Deng, Yanhong; Gu, Kangsheng; Cheng, Ying; Yuan, Xianglin; Xiao, Juxiang; Tai, Yanfei; Wang, Linna; Zou, Jianjun; Zhang, Yanqiao; Shen, Lin |
| 2012 | Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII | Wei, Jingyuan; Ouyang, Hongsheng; Wang, Yuhui; Pang, Daxin; Cong, Nathan X.; Wang, Tiedong; Leng, Bingfeng; Li, Dong; Li, Xiaoping; Wu, Rong; Ding, Yu; Gao, Fei; Deng, Yanhong; Liu, Bo; Li, Ziyi; Lai, Liangxue; Feng, Haihua; Liu, George; Deng, Xuming |
| 2019 | Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018) | Xu, Jianmin; Fan, Jia; Qin, Xinyu; Cai, Jianqiang; Gu, Jin; Wang, Shan; Wang, Xishan; Zhang, Suzhan; Zhang, Zhongtao; Ba, Yi; Bu, Jianhong; Cai, Jianhui; Cai, Sanjun; Zeng, Shan; Zeng, Zhaochong; Chen, Gong; Chen, Yu; Chen, Zihua; Chen, Zongyou; Cheng, Jiemin; Chi, Pan; Dai, Guanghai; Dai, Yong; Deng, Yanhong; Ding, Kefeng; Fang, Xuedong; Fu, Chuangang; Gong, Jianping; Hao, Chunyi; He, Yulong; Huang, Zhongcheng; Ji, Jiafu; Jia, Baoqing; Jiang, Kewei; Jin, Jing; Kong, Dalu; Lan, Ping; Li, Dechuan; Li, Guoli; Li, Jin; Li, Leping; Li, Yunfeng; Li, Zhixia; Liang, Houjie; Liang, Xiaobo; Lin, Feng; Lin, Jianjiang; Liu, Hongjun; Liu, Tianshu; Liu, Yunpeng; Pan, Hongming; Pan, Zhizhong; Pei, Haiping; Peng, Tao; Ren, Li; Shen, Lin; Song, Chun; Song, Tianqiang; Su, Xiangqian; Sun, Yihong; Tao, Min; Tian, Liguo; Wan, Desen; Wang, Jianping; Wang, Guiying; Wang, Guiyu; Wang, Haijiang; Wang, Jianhua; Wang, Lei; Wang, Xin; Wang, Yajie; Wang, Yi; Wang, Ziqiang; Wei, Ye; Wei, Dong; Xia, Feng; Xia, Jianguo; Xia, Lijian; Xing, Baocai; Xiong, Bin; Xu, Jianming; Xu, Nong; Xu, Ruihua; Xu, Ye; Xu, Zekuan; Xu, Zhongfa; Yang, Shujun; Yao, Hongwei; Ye, Yingjiang; Yu, Peiwu; Yuan, Ying; Zhang, Jun; Zhang, Keliang; Zhang, Wei; Zhang, Xiaotian; Zhang, Yanqiao; Zhang, Youcheng; Zhang, Zhen; Zhao, Qingchuan; Zhao, Ren; Zheng, Shu; Zhou, Aiping; Zhou, Jian; Zhou, Zongguang |
| 16-Feb-2024 | Clinical Benefit of Avapritinib in <i>KIT-</i>Mutant Gastrointestinal Stromal Tumors: A <i>Post Hoc</i> Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies | Heinrich, Michael C.; Zhang, Xinhua; Jones, Robin L.; George, Suzanne; Serrano, Cesar; Deng, Yanhong; Bauer, Sebastian; Cai, Shirong; Wu, Xin; Zhou, Yongjian; Tao, Kaixiong; Zheng, Zhichao; Zhang, Jun; Cui, Yuehong; Cao, Hui; Wang, Meining; Hu, Jin; Yang, Jason; Li, Jian; Shen, Lin |
| 1-Jun-2023 | Clinical efficacy of avapritinib in gastrointestinal stromal tumors (GIST) with different KIT genotypes: Post hoc analysis of the phase 1 NAVIGATOR and phase 1/2 CS3007-101 trials | Heinrich, Michael C.; Li, Jian; Zhang, Xinhua; Jones, Robin L.; George, Suzanne; Trent, Jonathan C.; Serrano, Cesar; Deng, Yanhong; Bauer, Sebastian; Cai, Shirong; Wu, Xin; Zhou, Yongjian; Tao, Kaixiong; Zheng, Zhichao; Zhang, Jun; Cui, Yuehong; Cao, Hui; Wang, Meining; Hu, Jin; Shen, Lin |
| 20-May-2020 | Early carcinoembryonic antigen (CEA) dynamics to predict fruquintinib efficacy in FRESCO, a 3+line metastatic colorectal carcinoma (mCRC) phase III trial. | Bai, Yuxian; Qin, Shukui; Li, Jin; Deng, Yanhong; Yang, Lei; Xu, Rui-hua; Chen, Zhendong; Zhong, Haijun; Pan, Hongming; Guo, Weijian; Shu, Yongqian; Yuan, Ying; Xu, Jianming; Shen, Lin; Wang, Ning; Zhang, Bin; Zhang, Qiang; Fan, Songhua; Guo, Xiaojun; Peng, Mengye |
| 2018 | Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial | Li, Jin; Qin, Shukui; Xu, Rui-Hua; Shen, Lin; Xu, Jianming; Bai, Yuxian; Yang, Lei; Deng, Yanhong; Chen, Zhen-dong; Zhong, Haijun; Pan, Hongming; Guo, Weijian; Shu, Yongqian; Yuan, Ying; Zhou, Jianfeng; Xu, Nong; Liu, Tianshu; Ma, Dong; Wu, Changping; Cheng, Ying; Chen, Donghui; Li, Wei; Sun, Sanyuan; Yu, Zhuang; Cao, Peiguo; Chen, Haihui; Wang, Jiejun; Wang, Shubin; Wang, Hongbing; Fan, Songhua; Hua, Ye; Su, Weiguo |
| 20-May-2020 | Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency. | Shen, Lin; Li, Jian; Deng, Yanhong; Zhang, Weijie; Zhou, Aiping; Guo, Weijian; Yang, Jianwei; Yuan, Ying; Zhu, Liangjun; Qin, Shukui; Xiang, Silong; Lu, Haolan; Gong, John; Xu, Ting; Liu, David |
| 2019 | Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition) | Li, Jian; Yuan, Ying; Yang, Fan; Wang, Yi; Zhu, Xu; Wang, Zhenghang; Zheng, Shu; Wan, Desen; He, Jie; Wang, Jianping; Ba, Yi; Bai, Chunmei; Bai, Li; Bai, Wei; Bi, Feng; Cai, Kaican; Cai, Muyan; Cai, Sanjun; Chen, Gong; Chen, Keneng; Chen, Lin; Chen, Pengju; Chi, Pan; Dai, Guanghai; Deng, Yanhong; Ding, Kefeng; Fan, Qingxia; Fang, Weijia; Fang, Xuedong; Feng, Fengyi; Fu, Chuangang; Fu, Qihan; Gu, Yanhong; He, Yulong; Jia, Baoqing; Jiang, Kewei; Lai, Maode; Lan, Ping; Li, Enxiao; Li, Dechuan; Li, Jin; Li, Leping; Li, Ming; Li, Shaolei; Li, Yexiong; Li, Yongheng; Li, Zhongwu; Liang, Xiaobo; Liang, Zhiyong; Lin, Feng; Lin, Guole; Liu, Hongjun; Liu, Jianzhong; Liu, Tianshu; Liu, Yunpeng; Pan, Hongming; Pan, Zhizhong; Pei, Haiping; Qiu, Meng; Qu, Xiujuan; Ren, Li; Shen, Zhanlong; Sheng, Weiqi; Song, Chun; Song, Lijie; Sun, Jianguo; Sun, Lingyu; Sun, Yingshi; Tang, Yuan; Tao, Min; Wang, Chang; Wang, Haijiang; Wang, Jun; Wang, Shubin; Wang, Xicheng; Wang, Xishan; Wang, Ziqiang; Wu, Aiwen; Wu, Nan; Xia, Lijian; Xiao, Yi; Xing, Baocai; Xiong, Bin; Xu, Jianmin; Xu, Jianming; Xu, Nong; Xu, Ruihua; Xu, Zhongfa; Yang, Yue; Yao, Hongwei; Ye, Yingjiang; Yu, Yonghua; Yu, Yueming; Yue, Jinbo; Zhang, Jingdong; Zhang, Jun; Zhang, Suzhan; Zhang, Wei; Zhang, Yanqiao; Zhang, Zhen; Zhang, Zhongtao; Zhao, Lin; Zhao, Ren; Zhou, Fuxiang; Zhou, Jian; Jin, Jing; Gu, Jin; Shen, Lin |
| Sep-2020 | ModifiedFOLFOXIRIWith or Without Cetuximab as Conversion Therapy in Patients withRAS/BRAFWild-TypeUnresectable Liver Metastases Colorectal Cancer: TheFOCULMMulticenter PhaseIITrial | Hu, Huabin; Wang, Kun; Huang, Meijin; Kang, Liang; Wang, Wei; Wang, Hui; Qiu, Meng; Lin, Rongbo; Zhang, Haibo; Lan, Ping; Wu, Xiaojian; Liu, Guangjian; Wan, Yunle; Liu, Ming; Zhou, Zhiyang; Huang, Yan; Li, Fangqian; Zhang, Jianwei; Cai, Yue; Ma, Tenghui; Zhou, Jiaming; Wang, Huaiming; Ling, Jiayu; Cai, Yonghua; Wu, Zehua; Luo, Shuangling; Ling, Li; Deng, Yanhong |
| Aug-2020 | National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version) | Sun, Yan; Zheng, Shu; Wan, Desen; Gu, Jin; Wang, Jianping; Zhang, Suzhan; Cai, Sanjun; Fang, Xuedong; Fu, Chuangang; Jia, Baoqing; Kong, Dalu; Lan, Ping; Pan, Zhizhong; Pei, Haiping; Qiu, Huizhong; Song, Chun; Wang, Guiying; Wang, Xishan; Wang, Ziqiang; Xu, Jianmin; Xu, Zhongfa; Yan, Jin; Ye, Yingjiang; Yu, Yueming; Zhang, Zhongtao; Zhao, Ren; Lian, Lei; Liu, Qian; Peng, Yifan; Shen, Lin; Xu, Ruihua; Li, Jin; Ba, Yi; Bai, Chunmei; Bai, Li; Deng, Yanhong; Li, Jian; Liu, Tianshu; Liu, Yunpeng; Pan, Hongming; Tao, Min; Xu, Jianming; Yuan, Xianglin; Yuan, Ying; Zhang, Yanqiao; Zhou, Aiping; Wang, Feng; Wang, Xicheng; Li, Yexiong; Zhang, Zhen; Cai, Yong; Gao, Yuanhong; Jin, Jing; Li, Yongheng; Liu, Shixin; Wang, Renben; Wu, Junxin; Zhang, Hongyan; Zhu, Li; Zhu, Yuan; Tang, Yuan; Liang, Zhiyong; Jin, Mulan; Liang, Li; Qiu, Zhiqiang; Sheng, Weiqi; Sun, Baocun; Xue, Weicheng; Zhou, Weixun; Sun, Yingshi; Dong, Jiangning; Wang, Yi; Yu, Tao; Zhang, Xiaoyan; Zhou, Zhiyang; Sun, Ruijia; Wang, Juan; Sun, Ruijia; Tang, Yuan; Wang, Feng; Wang, Juan; Zhou, Weixun; Yang, Yong; Chen, Jiajia; Chen, Yongkang; Cheng, Yu; Han, Zihan; Huang, An; Huang, Dandan; Li, Xin; Li, Yukun; Shi, Jingyi; Shi, Mengyuan; Song, Can; Wang, Hanyang; Xu, Jingxuan |
| Dec-2024 | Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring <i>FGFR2</i> gene amplification | Yuan, Jiajia; Shen, Lin; Liu, Tian Shu; Xu, Huiting; Yang, Jianwei; Wei, Jia; Jiang, Haiping; Deng, Yanhong; Pan, Hongming; Wang, Yusheng; Zhang, Xiaotian; Peng, Zhi; Qi, Changsong; Zhang, Lingli; Hsu, Peiwen; Song, Lin; Mu, Lei; Sun, Qiao; Gong, Jifang; Lyu, Cheng |
| Aug-2022 | Phase 2 study of tislelizumab monotherapy in previously treated, locally advanced, unresectable or metastatic microsatellite instability-high/mismatch repair-deficient solid tumors: Gynecological cancer subgroup | Wang, Dong; Zhang, Naiyi; Zang, Aimin; Wang, Jing; Huang, Yi; Shen, Lin; Li, Jian; Zhang, Yanqiao; Liu, Tianshu; Deng, Yanhong; Xu, Yaling; Li, Zhezhen; Wang, Yidi; Gao, Yunong |
| Feb-2021 | Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in FRESCO trial | Qin, Shukui; Li, Jin; Bai, Yuxian; Deng, Yanhong; Yang, Lei; Xu, Rui-Hua; Zhong, Haijun; Chen, Zhendong; Pan, Hongming; Guo, Weijian; Shu, Yongqian; Xu, Jianming; Peng, Cike; Chen, Yun; Li, Hongyan; Wang, Ning; Guo, Xiaojun; Peng, Mengye; Fan, Songhua; Shen, Lin |
| Apr-2022 | Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study | Wang, Jitao; Zhang, Qiran; Ai, Jingwen; Liu, Dengxiang; Liu, Chuan; Xiang, Huiling; Gu, Ye; Guo, Ying; Lv, Jiaojian; Huang, Yifei; Liu, Yanna; Xu, Dan; Chen, Shubo; Li, Jinlong; Li, Qianqian; Liang, Jing; Bian, Li; Zhang, Zhen; Guo, Xiaoqing; Feng, Yinong; Liu, Luxiang; Zhang, Xuying; Zhang, Yanliang; Xie, Faren; Jiang, Shujun; Qin, Wei; Wang, Xiaodong; Rao, Wei; Zhang, Qun; Tian, Qiuju; Zhu, Ying; Cong, Qingwei; Xu, Juan; Hou, Zhiyun; Zhang, Nina; Zhang, Aiguo; Zu, Hongmei; Wang, Yun; Yan, Zhaolan; Du, Xiufang; Hou, Aifang; Yan, Yan; Qiu, Yuanwang; Wu, Hangyuan; Hu, Shengjuan; Deng, Yanhong; Ji, Jiansong; Yang, Jie; Huang, Jiansheng; Zhao, Zhongwei; Zou, Shengqiang; Ji, Hailei; Ge, Guohong; Zhong, Li; He, Song; Yan, Xiaosong; Yangzhen, Bian Ba; Qu, Ci; Zhang, Liting; Yang, Shiying; Gao, Xiaoqin; Lv, Muhan; Zhu, Qingliang; Xu, Xinxin; Zeng, Qing-Lei; Qi, Xiaolong; Zhang, Wenhong |
| Sep-2020 | Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial | Li, Jin; Guo, Weijian; Bai, Yuxian; Deng, Yanhong; Yang, Lei; Chen, Zhendong; Zhong, Haijun; Xu, Ruihua; Pan, Hongming; Shu, Yongqian; Yuan, Ying; Zhou, Jianfeng; Xu, Nong; Liu, Tianshu; Ma, Dong; Wu, Changping; Cheng, Ying; Xu, Jianming; Chen, Donghui; Li, Wei; Sun, Sanyuan; Yu, Zhuang; Cao, Peiguo; Shen, Lin; Chen, Haihui; Wang, Shubin; Wang, Hongbing; Fan, Songhua; Guo, Xiaojun; Wang, Ning; Han, Rubing; Zhang, Bin; Qin, Shukui |
| 2016 | Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizuma | Kotaka, Masahito; Xu, Ruihua; Muro, Kei; Park, Young Suk; Morita, Satoshi; Iwasa, Satoru; Uetake, Hiroyuki; Nishina, Tomohiro; Nozawa, Hiroaki; Matsumoto, Hiroshi; Yamazaki, Kentaro; Han, Sae-Won; Wang, Wei; Ahn, Joong Bae; Deng, Yanhong; Cho, Sang-Hee; Ba, Yi; Lee, Keun-Wook; Zhang, Tao; Satoh, Taroh; Buyse, Marc E.; Ryoo, Baek-Yeol; Shen, Lin; Sakamoto, Junichi; Kim, Tae Won |
| 21-Jun-2021 | Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors | Li, Jian; Deng, Yanhong; Zhang, Weijie; Zhou, Ai-Ping; Guo, Weijian; Yang, Jianwei; Yuan, Ying; Zhu, Liangjun; Qin, Shukui; Xiang, Silong; Lu, Haolan; Gong, John; Xu, Ting; Liu, David; Shen, Lin |
